Health Care & Life Sciences » Biotechnology | Alexion Pharmaceuticals Inc.

Alexion Pharmaceuticals Inc.

Alexion Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
222.86 M
Public Float
213.41 M
Alexion Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.82
Market Cap
$29.22 B
Shares Outstanding
224.24 M
Public Float
222.46 M

Profile

Address
121 Seaport Boulevard
Boston Massachusetts 02210
United States
Employees -
Website http://www.alexion.com
Updated 07/08/2019
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include soliris, strensiq and kanuma. The company was founded by Joseph A.

Financials

View All

Ludwig N. Hantson
Chief Executive Officer & Director
David Richard Brennan
Chairman